Chief Scientific Officer

Kardigan: $254 Million Series B Closed To Advance Late-Stage Portfolio Of Personalized Cardiovascular Medicines

Lila Sciences' swollen first round, and other biofinancings

The Week’s 10 Biggest Funding Rounds: Biotech Dominates A Busy Week

Kardigan: $254 Million Series B Secured To Advance Late-Stage Cardiovascular Medicines

Director, Medical Affairs Strategy & Operations

Kardigan is a heart health company focused on making cardiovascular disease preventable and curable. They are seeking a dynamic and strategic Director of Medical Affairs Strategy & Operations to lead the development and execution of global medical affairs processes and initiatives, driving operational excellence and cross-functional alignment.

Sign up with Google

Sign in with Google